BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 20587506)

  • 1. Cardiac electrophysiological effects of nitric oxide.
    Tamargo J; Caballero R; Gómez R; Delpón E
    Cardiovasc Res; 2010 Sep; 87(4):593-600. PubMed ID: 20587506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current concepts of the ionic mechanisms of cardiac arrhythmias and the possible mechanisms of action of cardiac anti-arrhythmia agents].
    Porotikov VI; Lazarev AV; Glezer GA
    Usp Fiziol Nauk; 1984; 15(3):42-63. PubMed ID: 6089463
    [No Abstract]   [Full Text] [Related]  

  • 3. Electrophysiologic changes in heart failure: focus on pacemaker channels.
    Sartiani L; Stillitano F; Cerbai E; Mugelli A
    Can J Physiol Pharmacol; 2009 Feb; 87(2):84-90. PubMed ID: 19234571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cardiac ion channels via non-genomic action of sex steroid hormones: implication for the gender difference in cardiac arrhythmias.
    Furukawa T; Kurokawa J
    Pharmacol Ther; 2007 Jul; 115(1):106-15. PubMed ID: 17583354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of the nitric oxide-cGMP pathway exacerbates postischaemic heart injury in stroke-prone hypertensive rats.
    Itoh T; Haruna M; Abe K
    Exp Physiol; 2007 Jan; 92(1):147-59. PubMed ID: 17030559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels.
    Fischmeister R; Castro L; Abi-Gerges A; Rochais F; Vandecasteele G
    Comp Biochem Physiol A Mol Integr Physiol; 2005 Oct; 142(2):136-43. PubMed ID: 15927494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ["Sicilian gambit": pathophysiological approach to drug therapy of arrhythmia (lecture]].
    Sulimov VA
    Ter Arkh; 1999; 71(8):67-74. PubMed ID: 10515042
    [No Abstract]   [Full Text] [Related]  

  • 8. Repolarization of the cardiac action potential. Does an increase in repolarization capacity constitute a new anti-arrhythmic principle?
    Grunnet M
    Acta Physiol (Oxf); 2010 Feb; 198 Suppl 676():1-48. PubMed ID: 20132149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic drugs and ion channels: have we made the connection?
    Carmeliet E
    J Cardiovasc Electrophysiol; 1999 May; 10(5):755-9. PubMed ID: 10355931
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiac arrhythmogenesis: a tale of two clocks?
    Lei M; Huang CL
    Cardiovasc Res; 2020 Dec; 116(14):e205-e209. PubMed ID: 31800017
    [No Abstract]   [Full Text] [Related]  

  • 11. The cardiac ion channels: relevance to management of arrhythmias.
    Roden DM; George AL
    Annu Rev Med; 1996; 47():135-48. PubMed ID: 8712768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The electrophysiological properties of ranolazine: a metabolic anti-ischemic drug or an energy-efficient antiarrhythmic agent?
    Cingolani E; Lepor NE; Singh BN
    Rev Cardiovasc Med; 2011; 12(3):136-42. PubMed ID: 22080924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of nitric oxide synthase and nitric oxide-sensitive guanylate cyclase in the crustacean cardiac ganglion.
    Scholz NL; Labenia JS; de Vente J; Graubard K; Goy MF
    J Comp Neurol; 2002 Dec; 454(2):158-67. PubMed ID: 12412140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nitric oxide (NO) and NO cycle in myocardium: molecular, biochemical and physiological aspects].
    Reutov VP; Okhotin VE; Shuklin AV; Sorokina EG; Kositsyn NS; Gurin VN
    Usp Fiziol Nauk; 2007; 38(4):39-58. PubMed ID: 18064907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future of antiarrhythmic drugs.
    Darbar D; Roden DM
    Curr Opin Cardiol; 2006 Jul; 21(4):361-7. PubMed ID: 16755206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanically gated cardiac ion channels and their regulation by cytokines].
    Kamkin AG; Makarenko EIu
    Usp Fiziol Nauk; 2012; 43(4):3-44. PubMed ID: 23227720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use-dependent modulation of myocardial conduction by a new class of HERG agonists: deal breaker or cherry on top?
    Akar FG
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):930-2. PubMed ID: 20367661
    [No Abstract]   [Full Text] [Related]  

  • 18. Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism.
    Núñez L; Vaquero M; Gómez R; Caballero R; Mateos-Cáceres P; Macaya C; Iriepa I; Gálvez E; López-Farré A; Tamargo J; Delpón E
    Cardiovasc Res; 2006 Oct; 72(1):80-9. PubMed ID: 16876149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genesis and regulation of the heart automaticity.
    Mangoni ME; Nargeot J
    Physiol Rev; 2008 Jul; 88(3):919-82. PubMed ID: 18626064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac ion channels and mechanisms for protection against atrial fibrillation.
    Grunnet M; Bentzen BH; Sørensen US; Diness JG
    Rev Physiol Biochem Pharmacol; 2012; 162():1-58. PubMed ID: 21987061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.